In response to the ongoing COVID-19 public health emergency, the Centers for Disease Control and Prevention’s (CDC) National Center for Health Statistics (NCHS) is implementing three new diagnosis codes into the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) for reporting COVID-19 vaccination status, effective April 1, 2022.
|
Diagnosis Code |
Description |
|
Z28.310 |
Unvaccinated for COVID-19 |
|
Z28.311 |
Partially vaccinated for COVID-19 |
|
Z28.39 |
Other underimmunization status |
In response to the ongoing COVID-19 public health emergency, the Centers for Medicare & Medicaid Services (CMS) is implementing nine new procedure codes, to describe the introduction or infusion of therapeutics, including vaccines for COVID-19 treatment, into the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS), effective April 1, 2022.
|
Procedure Code |
Description |
|
XW013V7 |
Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 |
|
XW013W7 |
Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 |
|
XW023V7 |
Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7 |
|
XW023W7 |
Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7 |
|
XW0DXR7 |
Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 |
|
XW0G7R7 |
Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 |
|
XW0H7R7 |
Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7 |
|
XW023X7 |
Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 |
|
XW023Y7 |
Introduction of Other New Technology Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 |
These codes are available in NCTracks and providers may bill the codes effective with dates of service on or after April 1, 2022.
CONTACT
NCTracks Contact Center: 800-688-6696